Skip to content
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Neurology

Laurence-Moon Syndrome: A Patient Guide

At a Glance

Laurence-Moon syndrome is a rare genetic condition caused by changes in PNPLA6 that can affect vision, movement, development, and pituitary hormones. Symptoms vary widely, so coordinated care from neurology, eye, endocrine, and genetics specialists is important.

Receiving a rare diagnosis can be overwhelming, especially when the medical terminology has changed over the years. Laurence-Moon syndrome is a rare, multi-system genetic condition that is now understood to be part of a broader family of disorders caused by pathogenic variants (mutations) in the PNPLA6 gene [1].

For many years, this condition was frequently confused or grouped with Bardet-Biedl syndrome (BBS) because both can affect vision and hormones [2]. However, modern genetics has clarified that Laurence-Moon syndrome is a distinct condition with its own unique biological cause: it involves reduced or abnormal function of an enzyme called neuropathy target esterase (NTE), which is vital for the health of your nervous system [3]. Because they are biologically different, features commonly seen in BBS—such as extra fingers or toes (polydactyly), early-onset obesity, or severe kidney disease—are not usually reported in Laurence-Moon syndrome [2]. However, if you do experience unexpected symptoms, they should always be evaluated by your doctor rather than dismissed.

Living with this syndrome generally means managing changes in three core areas: the eyes, the brain, and the endocrine (hormone) system. Most individuals experience a progressive breakdown of the light-sensing layers of the eye, known as chorioretinal dystrophy, which often begins with a loss of night or peripheral vision [4]. Over time, the condition may also affect movement and coordination, leading to balance issues (ataxia) or a stiffness in the legs (spasticity) [5]. Additionally, the pituitary gland may not produce enough hormones to trigger puberty or maintain adult energy and growth levels, a challenge that is often managed with hormone replacement therapy [6].

The progression of PNPLA6-related disorders is highly variable. While some individuals have symptoms that change very slowly and remain independently ambulatory well into adulthood, others may experience earlier or more severe developmental, neurological, visual, or pituitary involvement [3][7]. Reliable individual prognostic or survival estimates are currently unavailable due to the rarity of the condition.

Because the condition affects multiple parts of the body, the most effective approach involves a dedicated, multidisciplinary team of specialists—including neurologists, eye doctors, endocrinologists, and genetic counselors—who work together to monitor your health [1]. The focus of your care is on supportive management and maximizing your quality of life. By using modern tools like low-vision rehabilitation, physical therapy, and precisely tailored hormone support, you and your medical team can navigate the condition proactively [8].

Common questions in this guide

What causes Laurence-Moon syndrome?
Laurence-Moon syndrome is caused by pathogenic changes in the PNPLA6 gene. These changes can reduce or alter the function of an enzyme important for nervous-system health, leading to effects on vision, movement, development, and pituitary hormones.
How is Laurence-Moon syndrome different from Bardet-Biedl syndrome?
The two conditions can both involve vision and hormone problems, but they have different biological causes. Extra fingers or toes, early-onset obesity, and severe kidney disease are not usually reported in Laurence-Moon syndrome, although any unexpected symptom should be assessed by a doctor.
What vision problems can Laurence-Moon syndrome cause?
Many people develop chorioretinal dystrophy, a progressive disorder affecting the light-sensing layers of the eye. Early changes often include reduced night vision or peripheral vision, and low-vision rehabilitation may help with daily activities.
Can Laurence-Moon syndrome affect movement and hormones?
Yes. Neurological effects may include balance problems, ataxia, and stiffness in the legs called spasticity. Pituitary hormone problems can affect puberty, growth, and energy levels, and hormone replacement may be used when appropriate.
What treatments and support are available for Laurence-Moon syndrome?
Care is usually supportive and tailored to the person's symptoms. A team that may include neurology, ophthalmology, endocrinology, and genetics specialists can coordinate low-vision rehabilitation, physical therapy, hormone support, and ongoing monitoring.
What is the outlook for someone with Laurence-Moon syndrome?
The course varies widely. Some people have slowly changing symptoms and remain able to walk independently into adulthood, while others have earlier or more severe visual, neurological, developmental, or pituitary involvement; reliable individual survival estimates are not currently available.

Get notified when new evidence is published on Laurence-Moon syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    PNPLA6 disorders: what's in a name?

    Liu J, Hufnagel RB

    Ophthalmic genetics 2023; (44(6)):530-538 doi:10.1080/13816810.2023.2254830.

    PMID: 37732399
  2. 2

    Prenatal diagnosis of Bardet Biedl Syndrome: A case report.

    Arora E, Fuks A, Meyer J, Chervenak J

    Radiology case reports 2023; (18(1)):326-330 doi:10.1016/j.radcr.2022.10.040.

    PMID: 36406960
  3. 3

    Multifaceted and Age-Dependent Phenotypes Associated With Biallelic PNPLA6 Gene Variants: Eight Novel Cases and Review of the Literature.

    Nanetti L, Di Bella D, Magri S, et al.

    Frontiers in neurology 2021; (12()):793547 doi:10.3389/fneur.2021.793547.

    PMID: 35069422
  4. 4

    Novel variants in PNPLA6 causing syndromic retinal dystrophy.

    Wu S, Sun Z, Zhu T, et al.

    Experimental eye research 2021; (202()):108327 doi:10.1016/j.exer.2020.108327.

    PMID: 33141049
  5. 5

    Homozygous PNPLA6 Mutation (p.Arg1183Trp) Associated With Isolated Cerebellar Ataxia: A Familial Case Report.

    Alawadhi A, Almarzooqi A, Khan M, Alrukn S

    Cureus 2026; (18(4)):e107039 doi:10.7759/cureus.107039.

    PMID: 42147656
  6. 6

    New insights into Oliver-McFarlane syndrome: adrenocortical hypofunction and variable expressivity in a Chinese sibling pair.

    Du C, Yu T, Liu S, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(6)):622-627 doi:10.1515/jpem-2025-0731.

    PMID: 41846525
  7. 7

    Oliver McFarlane syndrome: two new cases and a review of the literature.

    Lisbjerg K, Andersen MKG, Bertelsen M, et al.

    Ophthalmic genetics 2021; (42(4)):464-473 doi:10.1080/13816810.2021.1904419.

    PMID: 33818269
  8. 8

    Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders.

    Liu J, He Y, Lwin C, et al.

    Brain : a journal of neurology 2024; (147(6)):2085-2097 doi:10.1093/brain/awae055.

    PMID: 38735647

This Laurence-Moon syndrome overview is for informational purposes only and does not constitute medical advice. Your multidisciplinary care team should interpret symptoms, treatment options, and emergency plans for your specific situation.